SG Americas Securities’s Global Cord Blood Corporation CO Stock Holding History

SG Americas Securities’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-127,157	Closed	-$679K	–	3954
2021 Q2	$679K	Sell	127,157 -75,056	-37%	-$393K	﹤0.01%	1789
2021 Q1	$916K	Buy	+202,213	New	+$877K	﹤0.01%	1607
2019 Q3	–	Sell	-134,310	Closed	-$776K	–	3402
2019 Q2	$776K	Buy	134,310 +26,379	+24%	+$174K	0.01%	1597
2019 Q1	$758K	Buy	+107,931	New	+$713K	0.01%	1499
2018 Q1	–	Sell	-174,626	Closed	-$1.74M	–	3731
2017 Q4	$1.74M	Sell	174,626 -56,578	-24%	-$619K	0.02%	998
2017 Q3	$2.57M	Buy	231,204 +131,204	+131%	+$1.54M	0.02%	643
2017 Q2	$948K	Buy	+100,000	New	+$798K	0.01%	1447
2015 Q4	–	Sell	-144,358	Closed	-$869K	–	3145
2015 Q3	$869K	Hold	144,358	–	–	0.01%	895
2015 Q2	$889K	Buy	+144,358	New	+$886K	0.01%	1132

Other funds holding CO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

SG Americas Securities's CO Position: Q3 2021 in Review

SG Americas Securities sold out of Global Cord Blood Corporation (CO) in Q3 2021, closing a stake of 127,157 shares — an estimated $679K sold.

SG Americas Securities first reported a position in CO in Q2 2015 and held it in 9 quarters. The position peaked at $2.57M in Q3 2017. 28 funds tracked by Wall St. Rank hold CO as of Q3 2021.

SG Americas Securities reported no remaining Global Cord Blood Corporation position as of Q3 2021 after selling out during the quarter.
SG Americas Securities sold 127,157 Global Cord Blood Corporation shares in Q3 2021, an estimated $679K.
SG Americas Securities first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 9 quarters.
SG Americas Securities's Global Cord Blood Corporation position peaked at $2.57M in Q3 2017.
28 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2021.

Based on SG Americas Securities's 13F filing for Q3 2021, filed 1 Nov 2021.